Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.31 USD | -6.76% | -6.76% | +27.03% |
07/05 | AstraZeneca target raised; Antofagasta lowered | AN |
03/05 | AIB buys back EUR999 million worth of shares from Irish government | AN |
Sales 2024 * | 455.65Cr 495.9Cr 41TCr | Sales 2025 * | 434.04Cr 472.39Cr 39TCr | Capitalization | 1.22TCr 1.33TCr 1,11100Cr |
---|---|---|---|---|---|
Net income 2024 * | 176.2Cr 191.77Cr 16TCr | Net income 2025 * | 156.1Cr 169.89Cr 14TCr | EV / Sales 2024 * | 2.68 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 2.82 x |
P/E ratio 2024 * |
7.04
x | P/E ratio 2025 * |
7.33
x | Employees | 10,551 |
Yield 2024 * |
5.95% | Yield 2025 * |
6.31% | Free-Float | 68.01% |
Latest transcript on AIB Group plc
1 day | -6.76% | ||
1 week | -6.76% | ||
Current month | -6.76% | ||
1 month | +2.71% | ||
3 months | +12.69% | ||
6 months | +16.19% | ||
Current year | +27.03% |
Managers | Title | Age | Since |
---|---|---|---|
Colin Hunt
CEO | Chief Executive Officer | 54 | 01/16/01 |
Donal Galvin
DFI | Director of Finance/CFO | 50 | 01/13/01 |
Graham Fagan
CTO | Chief Tech/Sci/R&D Officer | - | 19/23/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fergal O’Dwyer
BRD | Director/Board Member | 64 | 22/21/22 |
James Pettigrew
CHM | Chairman | 65 | 28/21/28 |
Brendan McDonagh
BRD | Director/Board Member | 66 | 27/16/27 |
Date | Price | Change | Volume |
---|---|---|---|
04/24/04 | 5.31 | -6.76% | 3,820 |
Delayed Quote OTC Markets, June 04, 2024 at 08:39 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.08% | 58TCr | |
+17.85% | 31TCr | |
+15.97% | 25TCr | |
+19.26% | 21TCr | |
+20.65% | 18TCr | |
+24.83% | 17TCr | |
+8.61% | 16TCr | |
+9.66% | 15TCr | |
-13.23% | 14TCr |
- Stock Market
- Equities
- A5G Stock
- AIBRF Stock